BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24407852)

  • 1. Syzygium cumini is more effective in preventing the increase of erythrocytic ADA activity than phenolic compounds under hyperglycemic conditions in vitro.
    De Bona KS; Bonfanti G; Bitencourt PE; Cargnelutti LO; da Silva PS; da Silva TP; Zanette RA; Pigatto AS; Moretto MB
    J Physiol Biochem; 2014 Jun; 70(2):321-30. PubMed ID: 24407852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syzygium cumini inhibits adenosine deaminase activity and reduces glucose levels in hyperglycemic patients.
    Bopp A; De Bona KS; Bellé LP; Moresco RN; Moretto MB
    Fundam Clin Pharmacol; 2009 Aug; 23(4):501-7. PubMed ID: 19709327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of gallic acid and Syzygium cumini extract against oxidative stress-induced cellular injury in human lymphocytes.
    De Bona KS; Bonfanti G; Bitencourt PE; da Silva TP; Borges RM; Boligon A; Pigatto A; Athayde ML; Moretto MB
    Drug Chem Toxicol; 2016; 39(3):256-63. PubMed ID: 26364973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syzygium cumini seed extract ameliorates adenosine deaminase activity and biochemical parameters but does not alter insulin sensitivity and pancreas architecture in a short-term model of diabetes.
    Bitencourt PE; Bona KS; Cargnelutti LO; Bonfanti G; Pigatto A; Boligon A; Athayde ML; Pierezan F; Zanette RA; Moretto MB
    J Complement Integr Med; 2015 Sep; 12(3):187-93. PubMed ID: 25955284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous seed extract of Syzygium cumini inhibits the dipeptidyl peptidase IV and adenosine deaminase activities, but it does not change the CD26 expression in lymphocytes in vitro.
    Bellé LP; Bitencourt PE; Abdalla FH; Bona KS; Peres A; Maders LD; Moretto MB
    J Physiol Biochem; 2013 Mar; 69(1):119-24. PubMed ID: 22798209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocytic enzymes and antioxidant status in people with type 2 diabetes: beneficial effect of Syzygium cumini leaf extract in vitro.
    De Bona KS; Bellé LP; Bittencourt PE; Bonfanti G; Cargnelluti LO; Pimentel VC; Ruviaro AR; Schetinger MR; Emanuelli T; Moretto MB
    Diabetes Res Clin Pract; 2011 Oct; 94(1):84-90. PubMed ID: 21737173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syzygium cumini extract decrease adenosine deaminase, 5'nucleotidase activities and oxidative damage in platelets of diabetic patients.
    De Bona KS; Bellé LP; Sari MH; Thomé G; Schetinger MR; Morsch VM; Boligon A; Athayde ML; Pigatto AS; Moretto MB
    Cell Physiol Biochem; 2010; 26(4-5):729-38. PubMed ID: 21063110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of Syzygium cumini seed extract against methylmercury-induced sistemic toxicity in neonatal rats.
    Abdalla FH; Bellé LP; Bitencourt PE; De Bona KS; Zanette RA; Boligon AA; Athayde ML; Pigatto AS; Moretto MB
    Biometals; 2011 Apr; 24(2):349-56. PubMed ID: 21207116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syzygium cumini (L.) Skeels extracts; in vivo anti-nociceptive, anti-inflammatory, acute and subacute toxicity assessment.
    Qamar M; Akhtar S; Ismail T; Wahid M; Ali S; Nazir Y; Murtaza S; Abbas MW; Ziora ZM
    J Ethnopharmacol; 2022 Apr; 287():114919. PubMed ID: 34995693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenolic contents-based assessment of therapeutic potential of Syzygium cumini leaves extract.
    Ahmed R; Tariq M; Hussain M; Andleeb A; Masoud MS; Ali I; Mraiche F; Hasan A
    PLoS One; 2019; 14(8):e0221318. PubMed ID: 31465475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the antioxidant activity of Syzygium cumini leaves.
    Ruan ZP; Zhang LL; Lin YM
    Molecules; 2008; 13(10):2545-56. PubMed ID: 18927517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic effects of Syzygium cumini leaves: A non-hemolytic plant with potential against process of oxidation, glycation, inflammation and digestive enzymes catalysis.
    Franco RR; Ribeiro Zabisky LF; Pires de Lima Júnior J; Mota Alves VH; Justino AB; Saraiva AL; Goulart LR; Espindola FS
    J Ethnopharmacol; 2020 Oct; 261():113132. PubMed ID: 32673709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory Effects of
    Atale N; Mishra CB; Kohli S; Mongre RK; Prakash A; Kumari S; Yadav UCS; Jeon R; Rani V
    Oxid Med Cell Longev; 2021; 2021():8839479. PubMed ID: 33747350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of aqueous extract of syzigium cumini for its antihyperglycemic and antidyslipidemic properties in diabetic rats fed a high cholesterol diet-Role of PPARγ and PPARα.
    Sharma S; Pathak S; Gupta G; Sharma SK; Singh L; Sharma RK; Mishra A; Dua K
    Biomed Pharmacother; 2017 May; 89():447-453. PubMed ID: 28249245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of crude hydroalcoholic extract of Syzygium cumini (L.) Skeels leaves and continuous aerobic training in rats with diabetes induced by a high-fat diet and low doses of streptozotocin.
    Baldissera G; Sperotto ND; Rosa HT; Henn JG; Peres VF; Moura DJ; Roehrs R; Denardin EL; Dal Lago P; Nunes RB; Saffi J
    J Ethnopharmacol; 2016 Dec; 194():1012-1021. PubMed ID: 27794509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Effects of a Polyphenol-Rich Extract from
    Chagas VT; Coelho RMRS; Gaspar RS; da Silva SA; Mastrogiovanni M; Mendonça CJ; Ribeiro MNS; Paes AMA; Trostchansky A
    Oxid Med Cell Longev; 2018; 2018():5386079. PubMed ID: 30046378
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacognostical standardization and antidiabetic activity of Syzygium cumini (Linn.) barks (Myrtaceae) on streptozotocin-induced diabetic rats.
    Tripathi AK; Kohli S
    J Complement Integr Med; 2014 Jun; 11(2):71-81. PubMed ID: 24760764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiproliferative Activity and Apoptotic Efficiency of
    Siddika A; Das PK; Asha SY; Aktar S; Tareq ARM; Siddika A; Rakib A; Islam F; Khanam JA
    Anticancer Agents Med Chem; 2021; 21(6):782-792. PubMed ID: 32781964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioassay-guided fractionation and identification of α-amylase inhibitors from Syzygium cumini leaves.
    Poongunran J; Perera HK; Jayasinghe L; Fernando IT; Sivakanesan R; Araya H; Fujimoto Y
    Pharm Biol; 2017 Dec; 55(1):206-211. PubMed ID: 27927056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits.
    Rehman AA; Riaz A; Asghar MA; Raza ML; Ahmed S; Khan K
    BMC Complement Altern Med; 2019 Sep; 19(1):236. PubMed ID: 31481052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.